NCT00924482

Brief Summary

  1. 1.Compare measurements of cardiac output derived from electrical measurements from electrodes on an endotracheal tube (ECOM or Endotracheal Cardiac Output Monitor) to those made from a pulmonary artery thermodilution catheter.
  2. 2.Establish the safety and efficacy of the ECOM system.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
261

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2007

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 17, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 19, 2009

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

September 2, 2013

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

1.7 years

First QC Date

June 17, 2009

Results QC Date

September 23, 2010

Last Update Submit

November 6, 2023

Conditions

Keywords

cardiac outputECOMEndotracheal Cardiac Output MonitorPerioperative medical care

Outcome Measures

Primary Outcomes (1)

  • Comparison of ECOM Impedance and Thermodilution Cardiac Output Measurements

    Correlation measured via Linear regression between thermodilution and ECOM, included as r\^2 coefficient. Cardiac output measured by iced-thermodilution and impedance cardiography. Management of the patients done using (standard) thermodilution derived cardiac output measurements only. The ECOM endotracheal cardiac output measurements are for research purposes only and not used in the management of the patient. ECOM Impedance cardiography measured in the ICU when routine thermodilution cardiac output measurements are made. Endotracheal impedance measurements (ECOM) continued until tracheal extubation. Correlation with thermodilution measurements stopped when either the endotracheal tube or the thermodilution catheter was removed (post op day 0 routinely).

    perioperative period

Secondary Outcomes (1)

  • Safety of Device Measured by Number of Participants With Adverse Events

    perioperative period

Study Arms (1)

Single Arm - Device

OTHER

Placed ECOM endotracheal cardiac output monitor in patients undergoing cardiac surgery

Device: Placed ECOM endotracheal cardiac output monitor in patients undergoing cardiac surgery

Interventions

Measure cardiac output during perioperative period and compare to pulmonary artery thermodilution cardiac output measurements.

Single Arm - Device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients able to give informed consent.
  • Patients undergoing cardiac surgery which would routinely require:
  • an endotracheal tube
  • pulmonary artery catheter

You may not qualify if:

  • Patients who do not speak English.
  • Patients not competent to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Wallace AW, Salahieh A, Lawrence A, Spector K, Owens C, Alonso D. Endotracheal cardiac output monitor. Anesthesiology. 2000 Jan;92(1):178-89. doi: 10.1097/00000542-200001000-00030.

    PMID: 10638915BACKGROUND

Results Point of Contact

Title
Arthur Wallace, M.D., Ph.D.
Organization
University of California San Francisco

Study Officials

  • Art Wallace, MD, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2009

First Posted

June 19, 2009

Study Start

January 1, 2007

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

November 28, 2023

Results First Posted

September 2, 2013

Record last verified: 2023-11